Reply to Yu and Yu: Clarifying the role of carnitine metabolism in the ALDH9A1-associated immunotherapy resistance program
Proceedings of the National Academy of Sciences · 17.11.2026 · 123 (46)
DOI: 10.1073/pnas.2632549123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 30.10.2026. Verfasst von Hailei Du und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Thoracic Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.
- Department of Respiratory and Critical Care Medicine, Weifang Second People's Hospital, Weifang, Shandong 261041, China.
- Department of Intensive Care Medicine, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui…
- Department of Intensive Care Medicine, Anhui Provincial Cancer Hospital, Hefei, Anhui 230031, China.
- Department of Interventional Therapy, The First Hospital of Jilin University, Changchun, Jilin 130012, China.
- Department of Public Laboratory Platform, The First Hospital of Jilin University, Changchun, Jilin 130012, China.
ORCID-Profile: Hailei Du, Tong Lang, Xiaoxue Zha, Chao Qu, Ling Chen, Shihua Yao, Xing Feng, Zhaohui Jin
Zitieren
APA
Du, H., Lang, T., Zha, X., Qu, C., Chen, L., Yao, S., Feng, X., & Jin, Z. (2026). Reply to Yu and Yu: Clarifying the role of carnitine metabolism in the ALDH9A1-associated immunotherapy resistance program. Proceedings of the National Academy of Sciences, 123(46). https://doi.org/10.1073/pnas.2632549123
Vancouver
Du H, Lang T, Zha X, Qu C, Chen L, Yao S, et al. Reply to Yu and Yu: Clarifying the role of carnitine metabolism in the ALDH9A1-associated immunotherapy resistance program. Proceedings of the National Academy of Sciences. 2026;123(46). doi:10.1073/pnas.2632549123
BibTeX
@article{Du2026,
author = {Du, Hailei and Lang, Tong and Zha, Xiaoxue and Qu, Chao and Chen, Ling and Yao, Shihua and Feng, Xing and Jin, Zhaohui},
title = {Reply to Yu and Yu: Clarifying the role of carnitine metabolism in the ALDH9A1-associated immunotherapy resistance program},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
volume = {123},
number = {46},
doi = {10.1073/pnas.2632549123}
}
EUVIMED